China National Pharmaceutical Selected As Central Enterprise For Reform
This article was originally published in PharmAsia News
Executive Summary
The State-owned Assets Supervision and Administration Commission of the State Council held a press conference on July 15 and announced the pilot reform of six central enterprises, including the China National Pharmaceutical Group.